FCMI
Foresite Capital Management III Portfolio holdings
AUM
$37.9M
This Quarter Return
+5.38%
1 Year Return
-6.87%
3 Year Return
+443.49%
5 Year Return
+535.97%
10 Year Return
–
AUM
$72.1M
AUM Growth
+$72.1M
(-24%)
Cap. Flow
-$22.6M
Cap. Flow
% of AUM
-31.33%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
–
Reduced
–
Closed
2
Top Buys
No buys this quarter
Top Sells
| 1 |
Natera
NTRA
|
$14.5M |
| 2 |
FibroGen
FGEN
|
$8.14M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Aclaris Therapeutics
ACRS
$209M
| $35.2M | 48.8% |
1,954,904
| – | – |
|
|
XLRN
2
DELISTED
Acceleron Pharma Inc.
XLRN
| $18.7M | 25.92% |
108,630
| – | – |
|
|
VRNA
3
Verona Pharma
VRNA
$9.16B
| $6.09M | 8.44% |
1,111,112
| – | – |
|
|
CBAY
4
DELISTED
Cymabay Therapeutics
CBAY
| $5.99M | 8.31% |
1,641,804
| – | – |
|
|
EPZM
5
DELISTED
Epizyme, Inc
EPZM
| $5.11M | 7.09% |
998,278
| – | – |
|
6
Novavax
NVAX
$1.21B
| $1.04M | 1.44% |
5,000
| – | – |
|
|
7
FibroGen
FGEN
$47.8M
| – | – |
-305,784
| Closed | -$8.14M |
|
|
8
Natera
NTRA
$23.1B
| – | – |
-127,305
| Closed | -$14.5M |
|